473 related articles for article (PubMed ID: 18087999)
1. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
[TBL] [Abstract][Full Text] [Related]
2. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice.
Arefanian H; Tredget EB; Rajotte RV; Gill RG; Korbutt GS; Rayat GR
Diabetes; 2010 Apr; 59(4):958-66. PubMed ID: 20086231
[TBL] [Abstract][Full Text] [Related]
3. Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs Is Dependent on PD-1.
Arefanian H; Tredget EB; Mok DC; Ramji Q; Rafati S; Rodriguez-Barbosa J; Korbutt GS; Rajotte RV; Gill RG; Rayat GR
Cell Transplant; 2016; 25(2):327-42. PubMed ID: 26109574
[TBL] [Abstract][Full Text] [Related]
4. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB.
Rayat GR; Gill RG
Diabetes; 2005 Feb; 54(2):443-51. PubMed ID: 15677502
[TBL] [Abstract][Full Text] [Related]
5. Protection of porcine islet xenografts in mice using sertoli cells and monoclonal antibodies.
Ramji QA; Bayrack K; Arefanian H; Marcet-Palacios M; Bleackley RC; Rajotte RV; Rayat GR
Transplantation; 2011 Dec; 92(12):1309-15. PubMed ID: 22037619
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies.
Kobayashi T; Harb G; Rayat GR
Transplantation; 2005 Sep; 80(6):821-7. PubMed ID: 16210971
[TBL] [Abstract][Full Text] [Related]
7. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.
Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR
Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.
Appel MC; Banuelos SJ; Greiner DL; Shultz LD; Mordes JP; Rossini AA
Transplantation; 2004 May; 77(9):1341-9. PubMed ID: 15167588
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
11. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
12. Peri-graft porcine-specific CD4
Yoon IH; Chung H; Kim HJ; Nam HY; Shin JS; Kim YH; Park CG
Xenotransplantation; 2019 Sep; 26(5):e12533. PubMed ID: 31111577
[TBL] [Abstract][Full Text] [Related]
13. Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti-CD154 mAb.
Safley SA; Barber GF; Holdcraft RW; Gazda LS; Duncanson S; Poznansky MC; Sambanis A; Weber CJ
Xenotransplantation; 2020 Jul; 27(4):e12577. PubMed ID: 31903659
[TBL] [Abstract][Full Text] [Related]
14. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
15. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.
Nicolls MR; Coulombe M; Beilke J; Gelhaus HC; Gill RG
J Immunol; 2002 Nov; 169(9):4831-9. PubMed ID: 12391193
[TBL] [Abstract][Full Text] [Related]
16. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway.
Grochowiecki T; Gotoh M; Dono K; Takeda Y; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
Transplantation; 2000 Apr; 69(8):1567-71. PubMed ID: 10836363
[TBL] [Abstract][Full Text] [Related]
17. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
18. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
[TBL] [Abstract][Full Text] [Related]
19. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
20. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
